These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36905147)

  • 21. New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?
    Alanio A; Denis B; Hamane S; Raffoux E; Peffault de la Tour R; Touratier S; Bergeron A; Bretagne S
    J Antimicrob Chemother; 2016 Aug; 71(8):2075-8. PubMed ID: 27494830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
    Koehler P; Hamprecht A; Bader O; Bekeredjian-Ding I; Buchheidt D; Doelken G; Elias J; Haase G; Hahn-Ast C; Karthaus M; Kekulé A; Keller P; Kiehl M; Krause SW; Krämer C; Neumann S; Rohde H; La Rosée P; Ruhnke M; Schafhausen P; Schalk E; Schulz K; Schwartz S; Silling G; Staib P; Ullmann A; Vergoulidou M; Weber T; Cornely OA; Vehreschild MJ
    Int J Antimicrob Agents; 2017 Feb; 49(2):218-223. PubMed ID: 27989379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases.
    Zhao Y; Stensvold CR; Perlin DS; Arendrup MC
    J Antimicrob Chemother; 2013 Jul; 68(7):1497-504. PubMed ID: 23463213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment.
    Chowdhary A; Sharma C; Meis JF
    J Infect Dis; 2017 Aug; 216(suppl_3):S436-S444. PubMed ID: 28911045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Broad Allele-Specific TaqMan Real-Time PCR Method To Detect Triazole-Resistant Strains of Aspergillus fumigatus, Even with a Very Low Percentage of Triazole-Resistant Cells Mixed with Triazole-Susceptible Cells.
    Wang Q; Kontoyiannis DP; Li R; Chen W; Bu D; Liu W
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients.
    Spiess B; Seifarth W; Merker N; Howard SJ; Reinwald M; Dietz A; Hofmann WK; Buchheidt D
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3905-10. PubMed ID: 22526309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of Cyp51 A key mutations in Aspergillus fumigatus-a study on primary clinical samples of immunocompromised patients in the period of 1995-2013.
    Spiess B; Postina P; Reinwald M; Cornely OA; Hamprecht A; Hoenigl M; Lass-Flörl C; Rath PM; Steinmann J; Miethke T; Lauten M; Will S; Merker N; Hofmann WK; Buchheidt D
    PLoS One; 2014; 9(7):e103113. PubMed ID: 25072733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
    Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
    J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interspecies discrimination of A. fumigatus and siblings A. lentulus and A. felis of the Aspergillus section Fumigati using the AsperGenius
    Chong GM; Vonk AG; Meis JF; Dingemans GJ; Houbraken J; Hagen F; Gaajetaan GR; van Tegelen DW; Simons GF; Rijnders BJ
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):247-252. PubMed ID: 28007314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
    Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Wickes BL; Catano G; Patterson TF
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology, Drug Susceptibility, and Clinical Risk Factors in Patients With Invasive Aspergillosis.
    Wang Y; Zhang L; Zhou L; Zhang M; Xu Y
    Front Public Health; 2022; 10():835092. PubMed ID: 35493371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
    Snelders E; van der Lee HA; Kuijpers J; Rijs AJ; Varga J; Samson RA; Mellado E; Donders AR; Melchers WJ; Verweij PE
    PLoS Med; 2008 Nov; 5(11):e219. PubMed ID: 18998768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies.
    van de Peppel RJ; van der Beek MT; Visser LG; de Boer MGJ; Wallinga J
    Int J Antimicrob Agents; 2019 Mar; 53(3):284-293. PubMed ID: 30395989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.
    Guegan H; Robert-Gangneux F; Camus C; Belaz S; Marchand T; Baldeyrou M; Gangneux JP
    J Infect; 2018 Feb; 76(2):196-205. PubMed ID: 29248586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management.
    Lestrade PPA; Meis JF; Melchers WJG; Verweij PE
    Clin Microbiol Infect; 2019 Jul; 25(7):799-806. PubMed ID: 30580035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Airborne Aspergillus fumigatus spore concentration during demolition of a building on a hospital site, and patient risk determination for invasive aspergillosis including azole resistance.
    Wirmann L; Ross B; Reimann O; Steinmann J; Rath PM
    J Hosp Infect; 2018 Nov; 100(3):e91-e97. PubMed ID: 30056016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis.
    Moazam S; Eades CP; Muldoon EG; Moore CB; Richardson MD; Rautemaa-Richardson R
    Mycoses; 2020 Apr; 63(4):376-381. PubMed ID: 31981256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
    Rößler S; Bader O; Stölzel F; Sommer U; Spiess B; Geibel S; Buchheidt D; Groß U; Baretton G; Jacobs E; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28743702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
    J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.